Back

Effects of salvianolic acid A on β-amyloid mediated toxicity in Caenorhabditis elegans model of Alzheimer's disease

Yuen, C.-W.; Abdul Halim, M.; Najimudin, N.; Azzam, G.

2020-04-14 pharmacology and toxicology
10.1101/2020.04.13.040170 bioRxiv
Show abstract

Alzheimers disease (AD) is a brain disease attributed to the accumulation of extracellular senile plaques comprising {beta}-amyloid peptide (A{beta}). In this study, a transgenic Caenorhabditis elegans containing the human beta amyloid A{beta}42 gene which exhibited paralysis when expressed, was used to study the anti-paralysis effect of salvianolic acid A. Various concentrations ranging from 1 g/ml to 100 g/ml of salvianolic acid A were tested and exhibited the highest effect on the worm at the concentration of 100 g/ml. For anti-aggregation effect, 14 g/ml salvianolic acid A (within 4 mg/ml of Danshen) showed a significant level of inhibition of the formation of A{beta} fibrils. An amount of 100 g/ml of salvianolic acid A had the potential in reducing the ROS but did not totally obliterate the ROS production in the worms. Salvianolic acid A was found to delay the paralysis of the transgenic C. elegans, decrease A{beta}42 aggregation and decreased A{beta}-induced oxidative stress.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.